Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases.
11.20.2015 - JUXTAPID™ (lomitapide) Capsules Available on the Régie de l'Assurance Maladie du Québec (RAMQ) for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
02.11.2014 - Aegerion Pharmaceuticals Establishes Canadian Presence with Toronto office
02.10.2014 - Aegerion Pharmaceuticals’ JUXTAPID™ (lomitapide) Capsules Approved in Canada for the Treatment of Homozygous Familial Hypercholesterolemia (HoFH)
© 2014 Aegerion Pharmaceuticals, Inc. All rights reserved. AEGR/CA/316 02-14